Directorate change
June 01 2022 - 10:00AM
Directorate change
ALBION TECHNOLOGY & GENERAL VCT
PLC
DIRECTORATE CHANGE
LEI Code
213800TKJUY376H3KN16
This announcement includes information required under Listing
Rule 9.6.
As part of its succession planning, the Board of
Albion Technology & General VCT PLC (the “Company”) is pleased
to announce the appointment of Clive Richardson as a non-executive
Director of the Company with effect from 1 June 2022.
Clive has extensive experience across a range of
private and public international healthcare and technology focused
firms from start-ups to mid-cap companies. He was Head of Equities
Research for Investec Bank, and worked as a strategy consultant for
L.E.K. Consulting, a leading global strategy firm. He has held
non-executive director roles and served as an executive board
member on CIS Healthcare Ltd and Clinisys Ltd, both decision
support healthcare software companies. In his most recent role,
Clive served as COO and CEO for Akari Therapeutics Plc, a NASDAQ
listed biotechnology company.
The Board welcomes Clive and looks forward to
working with him over the coming years.
Robin ArchibaldChairman
For further information please contact:
Vikash HansraniAlbion Capital Group LLPCompany
SecretaryTel: 020 7601 1850
1 June 2022
Albion Technology & Gene... (LSE:AATG)
Historical Stock Chart
From Feb 2024 to Mar 2024
Albion Technology & Gene... (LSE:AATG)
Historical Stock Chart
From Mar 2023 to Mar 2024